• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阴离子型与阳离子型双分子层囊泡作为口服纳米载体增强亲水性药物利塞膦酸钠的递送

Anionic versus cationic bilosomes as oral nanocarriers for enhanced delivery of the hydrophilic drug risedronate.

机构信息

Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt; Department of Pharmaceutics, Faculty of Pharmacy and Drug Manufacturing, Pharos University in Alexandria, Alexandria, Egypt.

Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.

出版信息

Int J Pharm. 2019 Jun 10;564:410-425. doi: 10.1016/j.ijpharm.2019.04.069. Epub 2019 Apr 25.

DOI:10.1016/j.ijpharm.2019.04.069
PMID:31029657
Abstract

Albeit its well known potency as a postmenopausal osteoporosis treatment, Risedronate suffers from poor oral bioavailability and high oral toxicity. This is the first work to assess the potential of bilosomes to address challenges of RS oral delivery. Furthermore, impact of integrating cationic moiety into bilosomes on intestinal digestability and toxicity of RS nanovesicles was first investigated in this article. Prepared formulations were optimized based on physicochemical properties, digestibility, intestinal permeation and local toxicity studies. Optimized preparations were prepared by reversed phase evaporation technique with three extrusion cycles and loaded by 10 mg/ml RS. Molar lipid to bile salt to cholesterol ratio was adjusted to 4:1:1 at pH 5. Addition of cholesterol had significantly improved bilosomes stability to digestive media. Results also revealed that permeation of anionic vesicles increased permeation by 1.5 times more than RS solution and reduced drug toxicity by 2 folds. On the other hand, Cationic bilosomes showed good stability in GIT fluids but their induced oral toxicity could limit their use. In conclusion, bilosomes are superior over liposomes regarding protection of delivery system from the damaging effect of external in digestive bile salts. In addition, it decreases toxicity issues of orally administered drugs.

摘要

虽然雷洛昔芬作为绝经后骨质疏松症的治疗药物已有广泛的应用,但它存在口服生物利用度差和高口服毒性的问题。本研究首次评估了双层囊泡(bilosomes)在解决雷洛昔芬(RS)口服递送方面的潜力。此外,本文还首次研究了将阳离子部分整合到双层囊泡中对 RS 纳米囊泡的肠道消化性和毒性的影响。根据理化性质、消化性、肠道渗透性和局部毒性研究对制剂进行了优化。优化的制剂是通过反相蒸发技术,经过三个挤出循环,并以 10mg/ml 的 RS 进行装载制备而成。在 pH5 时,将摩尔脂质与胆汁盐和胆固醇的比例调整为 4:1:1。胆固醇的加入显著提高了双层囊泡对消化介质的稳定性。结果还表明,与 RS 溶液相比,阴离子囊泡的渗透增加了 1.5 倍,药物毒性降低了 2 倍。另一方面,阳离子双层囊泡在胃肠道内具有良好的稳定性,但它们引起的口服毒性可能限制了它们的应用。总之,双层囊泡在保护递药系统免受外部消化胆汁盐的破坏作用方面优于脂质体。此外,它还降低了口服药物的毒性问题。

相似文献

1
Anionic versus cationic bilosomes as oral nanocarriers for enhanced delivery of the hydrophilic drug risedronate.阴离子型与阳离子型双分子层囊泡作为口服纳米载体增强亲水性药物利塞膦酸钠的递送
Int J Pharm. 2019 Jun 10;564:410-425. doi: 10.1016/j.ijpharm.2019.04.069. Epub 2019 Apr 25.
2
Evaluation of bilosomes as nanocarriers for transdermal delivery of tizanidine hydrochloride: in vitro and ex vivo optimization.评价双分子层囊泡作为盐酸替扎尼定经皮传递的纳米载体:体外和离体优化。
J Liposome Res. 2019 Jun;29(2):171-182. doi: 10.1080/08982104.2018.1524482. Epub 2018 Nov 13.
3
Investigating the potential of employing bilosomes as a novel vesicular carrier for transdermal delivery of tenoxicam.研究将双分子层脂质体用作替诺昔康经皮给药新型囊泡载体的潜力。
Int J Pharm. 2015 May 15;485(1-2):329-40. doi: 10.1016/j.ijpharm.2015.03.033. Epub 2015 Mar 18.
4
Denatured globular protein and bile salt-coated nanoparticles for poorly water-soluble drugs: Penetration across the intestinal epithelial barrier into the circulation system and enhanced oral bioavailability.用于难溶性药物的变性球状蛋白和胆盐包被纳米颗粒:穿过肠道上皮屏障进入循环系统并提高口服生物利用度。
Int J Pharm. 2015 Nov 10;495(1):9-18. doi: 10.1016/j.ijpharm.2015.08.086. Epub 2015 Sep 4.
5
Readily restoring freeze-dried probilosomes as potential nanocarriers for enhancing oral delivery of cyclosporine A.冻干的原虫脂质体作为增强环孢素A口服递送的潜在纳米载体易于恢复。
Colloids Surf B Biointerfaces. 2016 Aug 1;144:143-151. doi: 10.1016/j.colsurfb.2016.04.006. Epub 2016 Apr 6.
6
Eprosartan mesylate loaded bilosomes as potential nano-carriers against diabetic nephropathy in streptozotocin-induced diabetic rats.甲磺酸依普罗沙坦载入双分子层囊泡作为潜在的纳米载体,用于治疗链脲佐菌素诱导的糖尿病大鼠的糖尿病肾病。
Eur J Pharm Sci. 2018 Jan 1;111:409-417. doi: 10.1016/j.ejps.2017.10.012. Epub 2017 Oct 10.
7
Oral immunization against hepatitis B using bile salt stabilized vesicles (bilosomes).使用胆盐稳定囊泡(双分子层脂质体)进行乙肝口服免疫。
J Pharm Pharm Sci. 2008;11(1):59-66. doi: 10.18433/j3k01m.
8
Niosomal carriers enhance oral bioavailability of carvedilol: effects of bile salt-enriched vesicles and carrier surface charge.非离子表面活性剂囊泡载体提高卡维地洛的口服生物利用度:富含胆盐的囊泡和载体表面电荷的影响。
Int J Nanomedicine. 2015 Jul 29;10:4797-813. doi: 10.2147/IJN.S84703. eCollection 2015.
9
Nanosized Liposomes Containing Bile Salt: A Vesicular Nanocarrier for Enhancing Oral Bioavailability of BCS Class III Drug.含胆盐的纳米脂质体:一种用于提高BCS III类药物口服生物利用度的囊泡纳米载体
J Pharm Pharm Sci. 2017;20(0):305-318. doi: 10.18433/J3CK88.
10
Bilosomes as a novel carrier for the cutaneous delivery for dapsone as a potential treatment of acne: preparation, characterization and skin deposition assay.将双分子层囊泡作为一种新型载体用于经皮递送达氟沙星治疗痤疮的研究:制备、表征和皮肤沉积研究。
J Liposome Res. 2020 Mar;30(1):1-11. doi: 10.1080/08982104.2019.1577256. Epub 2019 Jul 15.

引用本文的文献

1
Drug delivery systems incorporating bile salts: advancements since the conception of bilosomes.包含胆盐的药物递送系统:自双分子层脂质体概念提出以来的进展。
Ther Deliv. 2025 May;16(5):487-500. doi: 10.1080/20415990.2025.2469488. Epub 2025 Mar 24.
2
Targeted Sodium Acetate Liposomes for Hepatocytes and Kupffer Cells: An Oral Dual-Targeted Therapeutic Approach for Non-Alcoholic Fatty Liver Disease Alleviation.靶向肝细胞和库普弗细胞的醋酸钠脂质体:一种用于减轻非酒精性脂肪性肝病的口服双靶点治疗方法。
Nutrients. 2025 Mar 6;17(5):930. doi: 10.3390/nu17050930.
3
The Pharmaceutical and Pharmacological Potential Applications of Bilosomes as Nanocarriers for Drug Delivery.
双分子层脂质体作为药物递送纳米载体的药学和药理学潜在应用
Molecules. 2025 Mar 6;30(5):1181. doi: 10.3390/molecules30051181.
4
A Comprehensive Review of Challenges in Oral Drug Delivery Systems and Recent Advancements in Innovative Design Strategies.口服给药系统中的挑战及创新设计策略的最新进展综述
Curr Pharm Des. 2025;31(5):360-376. doi: 10.2174/0113816128338560240923073357.
5
Neuroprotective efficiency of celecoxib vesicular bilosomes for the management of lipopolysaccharide-induced Alzheimer in mice employing 2 full factorial design.采用 2 全因子设计评估塞来昔布囊泡双分子层用于治疗脂多糖诱导的阿尔茨海默病的神经保护效率。
Inflammopharmacology. 2024 Dec;32(6):3925-3942. doi: 10.1007/s10787-024-01522-y. Epub 2024 Jul 17.
6
Bone Targeting Nanoparticles for the Treatment of Osteoporosis.靶向骨的纳米粒子治疗骨质疏松症。
Int J Nanomedicine. 2024 Feb 12;19:1363-1383. doi: 10.2147/IJN.S444347. eCollection 2024.
7
Bilosomes and Biloparticles for the Delivery of Lipophilic Drugs: A Preliminary Study.用于亲脂性药物递送的双分子层脂质体和双分子层微粒:一项初步研究。
Antioxidants (Basel). 2023 Nov 21;12(12):2025. doi: 10.3390/antiox12122025.
8
Unlocking the Potential of Bilosomes and Modified Bilosomes: a Comprehensive Journey into Advanced Drug Delivery Trends.解锁双层囊泡和改良双层囊泡的潜力:深入了解先进药物传递趋势的综合之旅。
AAPS PharmSciTech. 2023 Nov 21;24(8):238. doi: 10.1208/s12249-023-02696-4.
9
Bilosomes as Nanocarriers for the Drug and Vaccine Delivery against Gastrointestinal Infections: Opportunities and Challenges.双分子层脂质体作为用于抗胃肠道感染的药物和疫苗递送的纳米载体:机遇与挑战
J Funct Biomater. 2023 Sep 1;14(9):453. doi: 10.3390/jfb14090453.
10
Novel Vesicular Bilosomal Delivery Systems for Dermal/Transdermal Applications.新型囊泡双体递药系统用于皮肤/经皮给药应用。
Curr Drug Deliv. 2024;21(7):961-977. doi: 10.2174/1567201820666230707161206.